CT screening for lung cancer: Coping with nihilistic recommendations

被引:45
作者
Miettinen, OS
Henschke, CI
机构
[1] Rockefeller Univ, New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY 10021 USA
[2] Rockefeller Univ, Weill Med Coll, Dept Med, New York, NY USA
[3] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[4] McGill Univ, Dept Med, Montreal, PQ, Canada
关键词
computed tomography (CT); utilization; lung neoplasms; CT; diagnosis; screening; staging;
D O I
10.1148/radiol.2213001644
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The practicing radiologist today is well persuaded that earlier diagnosis of lung cancer can be achieved with traditional-type radiography and especially with modern computed tomography. The practitioner also is confident that intervention in the context of earlier diagnosis is more effective in preventing death due to this otherwise fatal disease. The practitioner is thus inclined to consider such screening in a high-risk person with suitably long life expectancy, especially when asked to provide it. On the other hand, the practitioner is aware of official recommendations against lung cancer screening, said to be based on demonstrated lack of effectiveness of traditional radiographic screening. Some researchers have expressed concerns about screening-associated "overdiagnosis." Given this dilemma, the critically thinking practitioner is concerned to understand the foundation of the official nihilism in evidence and reasoning, as she or he suspects that something may be seriously wrong in this. This article is an attempt to help such a practitioner in this effort-an effort that in the end is rewarded by the comforting realization that the nihilistic recommendations and hesitation-provoking cautions are founded on pseudoevidence and specious reasoning.
引用
收藏
页码:592 / 596
页数:5
相关论文
共 18 条
  • [1] *AM CANC SOC, 1980, CA-CANCER J CLIN, V30, P189
  • [2] Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening
    Black, WC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16): : 1280 - 1282
  • [3] SCREENING FOR LUNG-CANCER
    EDDY, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (03) : 232 - 237
  • [4] FLEHINGER BJ, 1992, CHEST, V101, P13
  • [5] GREENWALD P, 1986, CANC CONTROL OBJECTI, P27
  • [6] Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO
  • [7] 2-S
  • [8] Early Lung Cancer Action Project: overall design and findings from baseline screening
    Henschke, CI
    McCauley, DI
    Yankelevitz, DF
    Naidich, DP
    McGuinness, G
    Miettinen, OS
    Libby, DM
    Pasmantier, MW
    Koizumi, J
    Altorki, NK
    Smith, JP
    [J]. LANCET, 1999, 354 (9173) : 99 - 105
  • [9] Medical imaging in the 21st century
    Hillman, BJ
    [J]. LANCET, 1997, 350 (9079) : 731 - 733
  • [10] Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up
    Marcus, PM
    Bergstralh, EJ
    Fagerstrom, RM
    Williams, DE
    Fontana, R
    Taylor, WF
    Prorok, PC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) : 1308 - 1316